-
Publications
-
Hyperpigmented vulvar nodules
Baumbick M, Chadha S, Choi JN Archives of Dermatological Research 2026 Dec 318 -
Secondary T-cell lymphomas after chimeric antigen receptor T-cell therapy in dermatology
Park JJ, Nguyen CV, Mittal S, Choi JN, Guitart J Journal of the American Academy of Dermatology 2026 Sep 95 884-885 -
Ecthymalike Ulcerations in Patients with Lung Cancer Treated with Combined Amivantamab and Osimertinib
Li S, Kim YJ, Choi E, Nguyen CV, Choi JN, Zheng L JAMA Dermatology 2026 Jul 162 756-758 -
Assessing Readability of Skin Cancer Screening Resources: A Comparison of Online Websites and ChatGPT Responses
Goorman E, Mittal S, Choi JN Journal of Cancer Education 2026 Jun 41 483-487 -
Vulvar and anogenital ulcerations induced by amivantamab: A case series
Mittal S, Goorman EJ, Prenner J, Guhan S, Zheng L, Choi JN, Nguyen CV JAAD Case Reports 2026 Apr 70 49-51 -
Clinical practice guidelines for the management of basal cell carcinoma in Gorlin syndrome
Cahn BA, Zhang R, Sidwell AM, Adam CM, Tiv J, Murrar R, Koh J, Griffin T, Nadir U, Yi MD, Ahmed A, Ma M, Koza E, Haq M, Shi V, Bale AE, Lewin JM, Christensen SR, Waldman A, Harmon CB, Alt-Holland A, Arkin LM, Morrison JC, Bogart K, Gregory MD, Lohman ME, Rossi A, Marghoob AA, Goldberg L, Jiang SB, Giordano CN, Choi JN, Teng JM, Mittal BB, Vidimos AT, Leffell DJ, Xu YG, Haber R, Storrs PA, Tsoukas M, Samie FH, Bickers DR, Nehal KS, Mosterd K, Billingsley EM, Epstein EH, Elston D, Hodge T, Breneiser J, Spiegel BA, Bissell S, Stephenson AG, Daum NS, Roth KB, Michalowski M, Shelley C, McGoldrick P, Nadin C, Weiss M, Rubenstein R, Kibbi N, Worley B, Chang AL, Harms KL, Pearlman R, Hirner J, Kim J, Schwartz RA, Bailey RK, Freites-Martinez A, Mirza AN, Castner N, Levenson JL, Whitson R, Golda N, Akin RS, Lawrence N, Demer A, Scott JF, Beveridge MG, Deng L, Sauder MB, Baumann BC, Bermudez R, Gill JG, Lambert WC, Cognetta AB, Krakowski AC, Blalock TW, Wasserman DI, Harper C, Dunbar-Jacob J, Patel AB, Chu EY, Sarin KY, Tang JY, Ruiz ES, Duffy K, Merritt B, Grushchak S, Behshad R, Lear W, Bartus CL, Kheterpal M, Somani AK, Eickstaedt J, Jung J, Smith E, Gold N, Walsh M, Subbiah V, Benedetto AV, Bar A, Bordeaux JS, Huang CC, Cohen JV, Yu SS, Yusuf MB, Lukens JN, Cartee TV, Fosko SW, Neel VA, Council ML, Shahwan KT, Srivastava D, Lauterbach M, Solomon JA, Brown MR, Beek MV, Hanke CW, Lee P, Maher IA, Brown TS, Konda S, Khushalani NI, Eisen DB, Carr DR, Saleeby E, Maloney M, Brown M, Cohen PR, Gilchrest BA, Miller CJ, Rohrer TE, Carucci JA, Swift J, Oro AE, Babakoohi S, Hawryluk EB, Grant-Kels JM, Desciak EB, Landers JT, Alam M Journal of the American Academy of Dermatology 2026 Feb 94 485-494 -
Analysis of Melanoma Educational Content and Skin of Color Representation on TikTok: Cross-Sectional Study
Jaguan D, Siddiqui Z, Choi JN JMIR Dermatology 2026 9 -
Bullous Eruption Associated With Loncastuximab Tesirine in a Patient With Diffuse Large B-Cell Lymphoma
Jaguan D, Nguyen C, Choi JN Journal of Cutaneous Pathology 2026 -
Efficacy of Phototherapy in Managing Cutaneous Immune-Related Adverse Events in Patients Treated With Checkpoint Inhibitors
Mittal S, Goorman E, Choi JN, Nguyen CV Journal of the American Academy of Dermatology 2026 Jan 94 347-349 -
Acute Graft-Versus-Host Disease: Diagnostic Challenges and Multidisciplinary Management in the Inpatient Setting
Lenga M, Choi E, Lin J, Choi JN Current Dermatology Reports 2025 Dec 14 -
Chimeric antigen receptor T-cell therapy-related T-cell malignancies: raising awareness of cutaneous manifestations
Park JJ, Nguyen CV, Choi JN, Guitart J British Journal of Dermatology 2025 Dec 193 1232-1233 -
Paradoxical Enhancement of Cancer Immunotherapy With JAK Inhibitors
Park JJ, Choi JN JAMA Dermatology 2025 Oct 161 997-998 -
High-dose vitamin D in a patient with docetaxel-induced photo-recall phenomenon
Mittal S, Prenner J, Choi JN JAAD Case Reports 2025 May 59 53-55 -
USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
Choi JN, Lacouture M, Andriessen A, Ho A, McLellan B, Mitchell E, Leventhal J Journal of Drugs in Dermatology 2025 Apr 24 s3-s14 -
Eruptive nevi in the setting of encorafenib: A case report and literature review
Lenga M, Venkatesh S, Choi JN JAAD Case Reports 2025 Feb 56 23-26 -
Recommended guidelines for screening for underlying malignancy in extramammary Paget's disease based on anatomic subtype
Author Collaboration EP, Kibbi N, Owen JL, Worley B, Alam M, Wang JX, Harikumar V, Downing MB, Aasi SZ, Aung PP, Barker CA, Bolotin D, Bordeaux JS, Cartee TV, Chandra S, Cho NL, Choi JN, Chung KY, Cliby WA, Dorigo O, Eisen DB, Fujisawa Y, Golda N, Halfdanarson TR, Iavazzo C, Brian Jiang SI, John EM, Kanitakis J, Keimig EL, Khan A, Linos E, Kim JY, Kuzel TM, Lawrence N, Leitao MM, MacLean AB, Maher IA, Mittal BB, Nehal KS, Ozog DM, Pettaway CA, Rajan N, Ross JS, Rossi AM, Servaes S, Solomon MJ, Thomas VD, Tolia M, Voelzke BB, Waldman A, Wong MK Journal of the American Academy of Dermatology 2025 Feb 92 261-268 -
Use of imiquimod topical therapy for management of malignant melanoma positive margins
Lewis K, Islam S, Alper DP, Carney MJ, Choi J, Leventhal J, Ariyan S, Baumann R, Olino K, Clune J Frontiers in Oncology 2025 15 -
INDIVIDUAL ARTICLE: USCOM IV Algorithm for the Prevention and Management of Targeted Therapy-Related Cutaneous Adverse Events
Leventhal J, Madiedo AS, Andriessen A, Choi JN, Ho A, McLellan B, Mitchell E, Lacouture M Journal of drugs in dermatology : JDD 2024 Dec 23 s3-436613s -
Successful treatment of in-transit metastatic melanoma with combination intralesional T-VEC and topical imiquimod immunotherapy
Lenga M, Choi E, Sosman J, Chandra S, Lam D, Johnson K, Schiemann L, Choi J Journal for ImmunoTherapy of Cancer 2024 Nov 12 -
Diffuse planar xanthomatosis in the setting of monoclonal gammopathy of undetermined significance
Lenga M, Choi JN Journal of Dermatology 2024 Oct 51 e327-e328 -
Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature
Iriarte C, Yeh JE, Alloo A, Boull C, Carlberg VM, Coughlin CC, Lara-Corrales I, Levy R, Nguyen CV, Oza VS, Patel AB, Rotemberg V, Shah SD, Zheng L, Miller CH, Hlobik M, Daigneault J, Choi JN, Huang JT, Vivar KL Supportive Care in Cancer 2024 Sep 32 -
Treatment of oral graft-versus-host disease with intraoral nbUVB phototherapy
Choi E, Lenga M, Nguyen CV, Zheng L, Froelich A, Centanni E, Choi JN Supportive Care in Cancer 2024 Jul 32 -
Anatomic Subtype Differences in Extramammary Paget Disease: A Meta-Analysis
Kibbi N, Owen JL, Worley B, Wang JX, Harikumar V, Aasi SZ, Chandra S, Choi JN, Fujisawa Y, Iavazzo C, Kim JY, Lawrence N, Leitao MM, MacLean AB, Ross JS, Rossi AM, Servaes S, Solomon MJ, Alam M JAMA Dermatology 2024 Apr 160 417-424 -
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy
Chen ST, Semenov YR, Alloo A, Bach DQ, Betof Warner A, Bougrine A, Burton L, Cappelli LC, Castells M, Cohen J, Dewan AK, Fadden R, Guggina L, Hegde A, Huang V, Johnson DB, Kaffenberger B, Kroshinsky D, Kwatra S, Kwong B, Lacouture ME, Larocca C, Leventhal J, Markova A, McDunn J, Mooradian MJ, Naidoo J, Choi J, Nambudiri V, Nelson CA, Patel AB, Pimkina J, Rine J, Rubin KM, Sauder M, Shaigany S, Shariff A, Sullivan RJ, Zubiri L, Reynolds KL, Leboeuf NR Journal for ImmunoTherapy of Cancer 2024 Apr 12 -
A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects
Lee O, Bazzi LA, Xu Y, Pearson E, Wang M, Hosseini O, Akasha AM, Choi JN, Karlan S, Pilewskie M, Kocherginsky M, Benante K, Helland T, Mellgren G, Dimond E, Perloff M, Heckman-Stoddard BM, Khan SA Biomedicine and Pharmacotherapy 2024 Feb 171 -
Immune Checkpoint Inhibitors and Systemic Side Effects: Overview for the Inpatient Dermatologist
Taritsa I, Choi JN Current Dermatology Reports 2023 Dec 12 225-232 -
Protocol for a feasibility trial (EXPRESS-C-GVHD) for an expressive helping intervention within a support group for cutaneous graft-versus-host-disease
Kaundinya T, Kye Y, El-Behaedi SE, Choi JN Archives of Dermatological Research 2023 Dec 315 2905-2912 -
USCOM Algorithm for the Prevention and Management of Cutaneous Immunotherapy-Related Adverse Events
Deutsch A, Lacouture M, Andriessen A, Choi JN, Ho AY, McLellan BN, Mitchell E, Leventhal JS Journal of Drugs in Dermatology 2023 Nov 22 S3-S10 -
Skin Infiltrate Composition as a Telling Measure of Responses to Checkpoint Inhibitors
Kosche C, Jaishankar D, Cosgrove C, Ramesh P, Hong S, Li L, Shivde RS, Bhuva D, White BE, Munir SS, Zhang H, Lu KQ, Choi JN, Le Poole IC JID Innovations 2023 Sep 3 -
Characterization of online support group resources for patients with dermatologic conditions
Kaundinya T, El-Behaedi S, Bilimoria S, Choi JN Archives of Dermatological Research 2023 Aug 315 1547-1552 -
Readability of Online Patient Education Materials for Graft-Versus-Host Disease
Kaundinya T, El-Behaedi S, Choi JN Journal of Cancer Education 2023 Aug 38 1363-1366 -
Content analysis and dermatologic gaps in online patient education materials for graft-versus-host disease
Kaundinya T, El-Behaedi S, Choi JN Archives of Dermatological Research 2023 May 315 1063-1066 -
High-Dose Vitamin D for the Management of Toxic Erythema of Chemotherapy in Hospitalized Patients
Nguyen CV, Zheng L, Zhou XA, Ernst MK, Kye Y, Choi JN, Lu KQ JAMA Dermatology 2023 Feb 159 219-222 -
Widespread sebaceous neoplasms in the setting of chronic immunosuppression with near-complete clearance on isotretinoin
El-Behaedi S, Ng S, Goyal PK, Pritzker R, Choi JN JAAD Case Reports 2022 Dec 30 59-62 -
Consensus on the clinical management of chronic radiation dermatitis and radiation fibrosis: a Delphi survey
Wilson BN, Shah R, Menzer C, Aleisa A, Sun MD, Kwong BY, Kaffenberger BH, Seminario-Vidal L, Barker CA, Stubblefield MD, Romesser PB, Fabbrocini G, Alam M, Abdulla F, Dulmage B, Sibaud V, Anadkat M, Mazer JM, Parikh D, McLellan B, Cartier H, Pugliese S, Wolkerstorfer A, Laubach HJ, LeBoeuf N, Leventhal J, Wan DC, Choi J, Tran TN, Anderson RR, Markova A, Rossi A British Journal of Dermatology 2022 Dec 187 1054-1056 -
Widespread cutaneous eruption following COVID-19 vaccine in the setting of immunotherapy
El-Behaedi S, Ng S, Goyal PK, Choi JN JAAD Case Reports 2022 Nov 29 48-50 -
Cutaneous manifestations of chimeric antigen receptor T-cell therapy: An introduction for dermatologists
Nusbaum KB, Dulmage B, Choi JN, Jaglowski SM, Korman AM Journal of the American Academy of Dermatology 2022 Sep 87 597-604 -
Oncodermatology: Advancing the Science and Care of Cancer Patients and Survivors
Bang AS, Anadkat MJ, Choi JN, LeBoeuf NR, Jung JY, Markova A, Gordon A, Rossi AM, Noor SJ, Sibaud V, Lacouture ME American Journal of Clinical Dermatology 2022 Jul 23 587-589 -
Palpable purpuric eruption mimicking vasculitis following avapritinib
Mohammed TO, Malik S, Hassan S, Solomon Z, Choi JN JAAD Case Reports 2022 Apr 22 89-92 -
Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease
Kibbi N, Owen JL, Worley B, Wang JX, Harikumar V, Downing MB, Aasi SZ, Aung PP, Barker CA, Bolotin D, Bordeaux JS, Cartee TV, Chandra S, Cho NL, Choi JN, Chung KY, Cliby WA, Dorigo O, Eisen DB, Fujisawa Y, Golda N, Halfdanarson TR, Iavazzo C, Jiang SI, Kanitakis J, Khan A, Kim JY, Kuzel TM, Lawrence N, Leitao MM, Maclean AB, Maher IA, Mittal BB, Nehal KS, Ozog DM, Pettaway CA, Ross JS, Rossi AM, Servaes S, Solomon MJ, Thomas VD, Tolia M, Voelzke BB, Waldman A, Wong MK, Zhou Y, Arai N, Brackett A, Ibrahim SA, Kang BY, Poon E, Alam M JAMA Oncology 2022 Apr 8 618-628 -
Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management
Musiek AC, Rieger KE, Bagot M, Choi JN, Fisher DC, Guitart J, Haun PL, Horwitz SM, Huen AO, Kwong BY, Lacouture ME, Noor SJ, Rook AH, Seminario-Vidal L, Vermeer MH, Kim YH Dermatology and Therapy 2022 Jan 12 29-40 -
Demodicosis Mimicking Papulopustular Eruption in the Setting of Targeted Therapy
Taritsa I, Walia S, Choi JN SKIN: Journal of Cutaneous Medicine 2022 Jan 6 48-51 -
Not just carriers: experiences of X-linked female heterozygotes
Choi J, Kane T, Propst L, Spencer S, Kostialik J, Arjunan A Journal of assisted reproduction and genetics 2021 Oct 38 2757-2767 -
US Cutaneous Oncodermatology Management (USCOM): A Practical Algorithm
Lacouture ME, Choi J, Ho A, Leventhal J, McLellan BN, Andriessen A, Sauder MB, Mitchell E Journal of Drugs in Dermatology 2021 Sep 20 S3-S18 -
Successful treatment of nodular human immunodeficiency virus–associated Kaposi sarcoma of the foot utilizing combination intralesional bleomycin and cryotherapy
Erickson MK, Choi JN JAAD Case Reports 2021 Apr 10 25-27 -
Association between halo nevi and melanoma in adults: A multicenter retrospective case series
Haynes D, Strunck JL, Said J, Tam I, Varedi A, Topham CA, Olamiju B, Wei BM, Erickson MK, Wang LL, Tan A, Stoner R, Hartman RI, Lilly E, Grossman D, Curtis JA, Westerdahl JS, Leventhal JS, Choi JN, Chu EY, Ming ME, Stein JA, Liebman TN, Berry E, Greiling TM Journal of the American Academy of Dermatology 2021 Apr 84 1164-1166 -
Utilization of immunotherapy among patients with stage 4 melanoma: An analysis of the National Cancer Database from 2012 to 2016
Shah PV, Choi JN, Fiessinger L, Nardone B, Nguyen CV, Liszewski W Journal of the American Academy of Dermatology 2021 Mar 84 811-814 -
Atezolizumab Caused Pityriasis Lichenoides-Like Drug Eruption Treated with Narrowband Ultraviolet B
Perez MM, Otto-Meyer S, Nguyen CV, Zheng L, Choi J, Guggina L SKIN: Journal of Cutaneous Medicine 2021 Mar 5 143-146 -
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity
Shannon VR, Anderson R, Blidner A, Choi J, Cooksley T, Dougan M, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson DB, Suarez-Almazor ME, Rapoport BL Supportive Care in Cancer 2020 Dec 28 6145-6157 -
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors
Dougan M, Blidner AG, Choi J, Cooksley T, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Anderson R, Rapoport BL Supportive Care in Cancer 2020 Dec 28 6129-6143 -
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities
Cooksley T, Girotra M, Ginex P, Gordon RA, Anderson R, Blidner A, Choi J, Dougan M, Glezerman I, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL Supportive Care in Cancer 2020 Dec 28 6175-6181 -
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors
Suarez-Almazor ME, Pundole X, Abdel-Wahab N, Johnson DB, Gupta D, Glezerman I, Cooksley T, Anderson R, Blidner A, Choi J, Dougan M, Ginex P, Girotra M, Shannon VR, Rapoport BL Supportive Care in Cancer 2020 Dec 28 6159-6173 -
Cancer immunotherapy–related adverse events: causes and challenges
Blidner AG, Choi J, Cooksley T, Dougan M, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL, Anderson R Supportive Care in Cancer 2020 Dec 28 6111-6117 -
Management of Immune-Related Cutaneous Adverse Reactions to PD-1 and PD-L1 Inhibitors for the Inpatient Dermatologist
Chadha S, Para AJ, Choi J Current Dermatology Reports 2020 Dec 9 231-243 -
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitors
Choi J, Anderson R, Blidner A, Cooksley T, Dougan M, Glezerman I, Ginex P, Girotra M, Gupta D, Johnson D, Shannon VR, Suarez-Almazor M, Rapoport BL, Lacouture ME Supportive Care in Cancer 2020 Dec 28 6119-6128 -
Cutaneous Toxicities of PI3K Inhibitors: A Series of Two Cases and Review of the Literature
Chadha SA, Shastry JL, Sunshine JC, Choi J, Guggina L SKIN: Journal of Cutaneous Medicine 2020 Nov 4 585-590 -
Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program
Jimenez J, Gwillim EC, Kosche C, Figueiredo A, Rauck C, Rangel SM, Choi J, West DP, Nardone B, Lacouture ME Journal of the American Academy of Dermatology 2020 Sep 83 955-957 -
Permanent chemotherapy-induced alopecia: awareness and attitudes among health care providers
Stoehr JR, Kosche C, Choi JN Supportive Care in Cancer 2020 Jun 28 2887-2890 -
Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature
Kosche C, Stout M, Sosman J, Lukas RV, Choi JN Melanoma research 2020 Jun 30 313-316 -
Successful treatment of in-transit metastatic melanoma in a renal transplant patient with combination T-VEC/Imiquimod immunotherapy
Sunshine JC, Sosman J, Shetty A, Choi JN Journal of Immunotherapy 2020 May 43 149-152 -
Current evidence for safety and efficacy of anti–programmed cell-death 1 agents in the treatment of cutaneous squamous cell carcinoma: A systematic review
Sadowsky LM, Kosche C, West DP, Choi JN Journal of the American Academy of Dermatology 2020 Feb 82 522-524 -
Verrucous Keratoses Associated with Checkpoint Inhibitor Immunotherapy
Owen JL, Kosche C, Choi JN SKIN: Journal of Cutaneous Medicine 2020 Jan 4 64-67 -
Fractional CO2 laser for the treatment of sclerodermatous cGVHD
Labadie JG, Kosche C, Kyllo R, Johnson T, Shumaker PR, Alam M, Choi JN Journal of Cosmetic and Laser Therapy 2020 Jan 22 49-51 -
Sebaceous carcinoma: evidence-based clinical practice guidelines
Owen JL, Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA, Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw SH, Cartee TV, Chandra S, Cho NL, Choi JN, Council ML, Demirci H, Eisen DB, Esmaeli B, Golda N, Huang CC, Ibrahim SF, Jiang SB, Kim J, Kuzel TM, Lai SY, Lawrence N, Lee EH, Leitenberger JJ, Maher IA, Mann MW, Minkis K, Mittal BB, Nehal KS, Neuhaus IM, Ozog DM, Petersen B, Rotemberg V, Samant S, Samie FH, Servaes S, Shields CL, Shin TM, Sobanko JF, Somani AK, Stebbins WG, Thomas JR, Thomas VD, Tse DT, Waldman AH, Wong MK, Xu YG, Yu SS, Zeitouni NC, Ramsay T, Reynolds KA, Poon E, Alam M The Lancet Oncology 2019 Dec 20 e699-e714 -
A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia
Capriotti KD, Anadkat M, Choi J, Kaffenberger B, McLellan B, Barone S, Kukoyi O, Goldfarb S, Lacouture M Investigational New Drugs 2019 Dec 37 1247-1256 -
Cutaneous Adverse Reactions of Anticancer Agents
Kaul S, Kaffenberger BH, Choi JN, Kwatra SG Dermatologic Clinics 2019 Oct 37 555-568 -
Evidence-Based Clinical Practice Guidelines for Microcystic Adnexal Carcinoma: Informed by a Systematic Review
Worley B, Owen JL, Barker CA, Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw S, Cartee TV, Chandra S, Cho N, Choi J, Council ML, Eisen DB, Golda N, Huang CC, Ibrahim SF, Jiang SI, Kim J, Lacutoure M, Lawrence N, Lee EH, Leitenberger JJ, Maher IA, Mann M, Minkis K, Mittal B, Nehal KS, Neuhaus I, Ozog DM, Petersen B, Samie F, Shin TM, Sobanko JF, Somani AK, Stebbins WG, Thomas JR, Thomas V, Tse D, Waldman A, Xu YG, Yu SS, Zeitouni NC, Ramsay T, Poon E, Alam M JAMA Dermatology 2019 Sep 155 1059-1068 -
Widespread cutaneous nontuberculous mycobacterial infection in the absence of bacteremia mimicking leukemia cutis
Musharbash M, Para A, Choi J JAAD Case Reports 2019 Aug 5 679-681 -
Radiation-induced morphea: Association with autoimmune comorbidities, severity, and response to therapy
Mittal A, Mittal V, Panse G, Choi JN, Kwong BY, Leventhal JS Journal of the American Academy of Dermatology 2019 Jul 81 260-262 -
Rare presentation of cutaneous lung cancer metastasis presenting as carcinoma erysipeloides
Kwa MC, Dulmage BO, Shastry JL, Yazdan P, Choi JN JAAD Case Reports 2019 Apr 5 332-335 -
Off-Label Use of Topical Minoxidil in Alopecia: A Review
Stoehr JR, Choi JN, Colavincenzo M, Vanderweil S American Journal of Clinical Dermatology 2019 Apr 20 237-250 -
Rare case of leukemia cutis presenting as erythroderma in a patient with acute myeloid leukemia
Donaldson M, Ebia MI, Owen JL, Choi JN JAAD Case Reports 2019 Feb 5 121-123 -
Widespread subacute cutaneous lupus erythematosus in a patient receiving checkpoint inhibitor immunotherapy with ipilimumab and nivolumab
Kosche C, Owen JL, Choi JN Dermatology online journal 2019 25 -
Bullous dermatoses secondary to anti-PD-L1 agents: A case report and review of the literature
Kosche C, Owen JL, Sadowsky LM, Choi JN Dermatology online journal 2019 25 -
Dermatologic Reactions to Novel Immune Checkpoint Inhibitors
Ebia MI, Choi JN Current Dermatology Reports 2018 Dec 7 227-238 -
Vitiligo in a patient undergoing nivolumab treatment for non–small cell lung cancer
Kosche C, Mohindra N, Choi JN JAAD Case Reports 2018 Nov 4 1042-1044 -
Management of Persistent Pruritus and Lichenoid Reaction Secondary to Nivolumab With Narrowband Ultraviolet B Phototherapy
Donaldson M, Owen JL, Chae YK, Choi JN Frontiers in Oncology 2018 Sep 8 -
Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer
Chu CY, Choi J, Eaby-Sandy B, Langer CJ, Lacouture ME Oncologist 2018 Aug 23 891-899 -
Cutaneous eruption secondary to immunotherapy formetastatic melanoma limited to sites of locoregional melanoma metastases: A possible variant of locus minoris resistentiae
Donaldson M, Owen JL, Choi JN JAMA Dermatology 2018 Jul 154 846-847 -
Promoting early detection of melanoma during the mammography experience
Rzepecki AK, Jain N, Ali Y, Chavez L, Choi J, Schlosser B, Liko-Hazizi E, Friedewald SM, Robinson JK International Journal of Women's Dermatology 2017 Dec 3 195-200 -
Delayed presentation of toxic epidermal necrolysis-like cutaneous acute graft-versus-host disease in the setting of recent immunosuppressant discontinuation
Goyal PK, Xu S, Choi J Dermatology online journal 2017 Oct 23 -
Management of skin adverse events associated with immune checkpoint inhibitors in patients with melanoma: A nursing perspective
Thebeau M, Rubin K, Hofmann M, Grimm J, Weinstein A, Choi JN Journal of the American Association of Nurse Practitioners 2017 May 29 294-303 -
Inverse lichenoid drug eruption associated with nivolumab
Guggina LM, Yanes DA, Choi JN JAAD Case Reports 2017 Jan 3 7-9 -
Clinical and histologic features of lichenoid mucocutaneous eruptions due to anti-programmed cell death 1 and anti-programmed cell death ligand 1 immunotherapy
Shi VJ, Rodic N, Gettinger S, Leventhal JS, Neckman JP, Girardi M, Bosenberg M, Choi JN JAMA Dermatology 2016 Oct 152 1128-1136 -
Oncofertility considerations in adolescents and young adults given a diagnosis of melanoma: Fertility risk of Food and Drug Administration–approved systemic therapies
Walter JR, Xu S, Paller AS, Choi JN, Woodruff TK Journal of the American Academy of Dermatology 2016 Sep 75 528-534 -
Cutaneous manifestations of nontargeted and targeted chemotherapies
Shi VJ, Levy LL, Choi JN Seminars in oncology 2016 Jun 43 419-425 -
Inverse psoriasiform eruption during pembrolizumab therapy for metastatic melanoma
Totonchy MB, Ezaldein HH, Ko CJ, Choi JN JAMA Dermatology 2016 May 152 590-592 -
Cutaneous vasculopathy as an adverse effect of the anti-vascular endothelial growth factor agent axitinib
Shi VJ, Galan A, Odell ID, Choi JN JAMA Dermatology 2016 Feb 152 222-223 -
Melanoma: Clinical presentations
Kibbi N, Kluger H, Choi JN 2016 107-129 -
Periocular Melanoma in Situ Treated with Imiquimod
Elia MD, Lally SE, Hanlon AM, Choi JN, Servat JJ, Shields JA, Shields CL, Levin F Ophthalmic plastic and reconstructive surgery 2016 32 371-373 -
Treatment of in-transit melanoma with intralesional Bacillus Calmette-Guérin (BCG) and topical imiquimod 5% cream: A report of 3 cases
Kibbi N, Ariyan S, Faries M, Choi JN Journal of Immunotherapy 2015 Oct 38 371-375 -
Congenital nevi versus metastatic melanoma in a newborn to a mother with malignant melanoma - Diagnosis supported by sex chromosome analysis and Imaging Mass Spectrometry
Alomari AK, Glusac EJ, Choi J, Hui P, Seeley EH, Caprioli RM, Watsky KL, Urban J, Lazova R Journal of Cutaneous Pathology 2015 Oct 42 757-764 -
A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies
Chan A, Cameron MC, Garden B, Boers-Doets CB, Schindler K, Epstein JB, Choi J, Beamer L, Roeland E, Russi EG, Bensadoun RJ, Teo YL, Chan RJ, Shih V, Bryce J, Raber-Durlacher J, Gerber PA, Freytes CO, Rapoport B, LeBoeuf N, Sibaud V, Lacouture ME Supportive Care in Cancer 2015 Aug 23 2231-2244 -
Using topical imiquimod for the management of positive in situ margins after melanoma resection
Pandit AS, Geiger EJ, Ariyan S, Narayan D, Choi JN Cancer Medicine 2015 Apr 4 507-512 -
Eruptive melanocytic nevi heralding the diagnosis of metastatic malignant melanoma: A case report
Kibbi N, Ariyan S, Slogoff F, Lazova R, Choi JN JAAD Case Reports 2015 Apr 1 74-76 -
Pregabalin for the treatment of painful hand-foot skin reaction associated with dabrafenib
Lilly E, Burke M, Kluger H, Choi J JAMA Dermatology 2015 Jan 151 102-103 -
Dermatologic adverse events to chemotherapeutic agents, Part 2: BRAF inhibitors, MEK inhibitors, and ipilimumab
Choi JN Seminars in Cutaneous Medicine and Surgery 2014 33 40-48 -
Subacute cutaneous lupus erythematosus induced by chemotherapy: Gemcitabine as a causative agent
Wiznia LE, Subtil A, Choi JN JAMA Dermatology 2013 Sep 149 1071-1075 -
The Vulvovaginal Symptoms Questionnaire: A questionnaire for measuring vulvovaginal symptoms in postmenopausal women
Erekson EA, Yip SO, Wedderburn TS, Martin DK, Li FY, Choi JN, Kenton KS, Fried TR Menopause 2013 Sep 20 973-979 -
Vemurafenib (PLX-4032)-induced keratoses: Verrucous but not verrucae
Ko CJ, McNiff JM, Iftner A, Iftner T, Choi JN Journal of the American Academy of Dermatology 2013 Aug 69 e95-e96 -
Dermatological adverse events from BRAF inhibitors: A growing problem
Belum VR, Fischer A, Choi JN, Lacouture ME Current oncology reports 2013 Jun 15 249-259 -
Neutrophilic dermatosis after azathioprine exposure
Cyrus N, Stavert R, Mason AR, Ko CJ, Choi JN JAMA Dermatology 2013 May 149 592-597 -
Unique presentations of epidermal growth factor receptor inhibitor-induced papulopustular eruption related to bacterial superinfection
Wiznia LE, Choi JN Dermatology online journal 2013 Mar 19 8 -
Late Dermatologic Conditions
Choi JN 2013 Jan 337-364 -
Medical students' and residents' clinical and educational experiences with defensive medicine
O'Leary KJ, Choi J, Watson K, Williams MV Academic Medicine 2012 Feb 87 142-148 -
Cutaneous Rosai-Dorfman disease of the right ear responsive to radiotherapy
Bunick CG, Leffell D, Bosenberg M, Yahalom J, Choi JN Journal of the American Academy of Dermatology 2012 67 e225-e226 -
Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
Choi JN Clinics in Dermatology 2011 Nov 29 587-601 -
Melanoma and Nevi: Detection and Diagnosis
Choi JN, Hanlon A, Leffell D Current Problems in Cancer 2011 Jul 35 138-161 -
Newly diagnosed Ehlers-Danlos syndrome in an adult with elastosis perforans serpiginosa
Ahmadi J, Choi JN Journal of the American Academy of Dermatology 2011 Jul 65 226-227 -
Erythroderma and spontaneous blistering in a 49-year-old man.
Trufant JW, Christensen SR, McNiff JM, Choi JN Archives of Dermatology 2010 Dec 146 1419-1424 -
Fatal HHV6 infection in an immunocompromised patient presenting with skin involvement
Galan A, McNiff JM, Choi JN, Lazova R Journal of Cutaneous Pathology 2010 Feb 37 277-281
-
Hyperpigmented vulvar nodules
Jennifer Choi, M.D.
- Dermatology - General
- Oncodermatology
Biography
Jennifer Choi, M.D., is a Professor and Vice Chair of Academic and Faculty Affairs in the Department of Dermatology at UT Southwestern Medical Center. She also serves as Assistant Designated Institutional Official for Graduate Medical Education.
A nationally recognized leader in oncodermatology, Dr. Choi provides specialized dermatologic care for patients undergoing cancer treatment. Her clinical expertise centers on the recognition and management of the mucocutaneous complications of cancer therapy, including:
- Skin toxicities related to chemotherapy, immunotherapy, and radiation
- Skin infections in immunosuppressed patients
- Dermatologic complications of hematopoietic stem cell and solid organ transplantation
Dr. Choi has been instrumental in establishing oncodermatology as an internationally recognized dermatologic subspecialty. She founded the Yale Oncodermatology Clinic, established Northwestern’s Division of Oncodermatology – the first of its kind – and is one of the founding members of the Oncodermatology Society. She directs multiple clinical research trials focused on preventing and treating the cutaneous side effects of cancer therapy and advancing evidence-based care in a rapidly evolving field.
Dr. Choi also cares for patients with melanoma, nonmelanoma skin cancer, and rare cutaneous malignancies. She maintains a comprehensive medical and surgical dermatology practice and brings extensive experience with complex therapeutics, including biologic agents, systemic immunosuppressants, intralesional therapies, and phototherapy.
She has had more than 140 scholarly works published, including more than 100 peer-reviewed journal articles, as well as book chapters and national consensus guidelines. She has delivered more than 100 invited lectures at national and international meetings.
Dr. Choi is a member of numerous professional associations, including:
- American Academy of Dermatology, for which she serves as Chair of the Academic Dermatology Leadership Program
- American Dermatological Association
- Women’s Dermatologic Society
- Medical Dermatology Society
- Oncodermatology Society
- Alpha Omega Alpha Honor Society
She serves on the editorial board of the Journal of the American Academy of Dermatology Case Reports and has served on numerous scientific and medical advisory boards.
Dr. Choi has received multiple awards, including:
- The Northwestern Outstanding Teacher Award, Mentor of the Year Award, and Teacher of the Year Award
- Women’s Dermatologic Society Mentor of the Year Award
- Melanoma Research Foundation Compassionate Care Award
She is also passionate about community service and patient education and has provided free skin cancer screenings and given lectures to community cancer support organizations.
Dr. Choi earned a Bachelor of Arts from Harvard University and her medical degree from Yale School of Medicine. She completed an internship in internal medicine at Brigham and Women's Hospital/Harvard Medical School and a residency in dermatology at Yale, where she served as chief resident.
She subsequently spent eight years on the Yale faculty as an Assistant Professor of dermatology. In 2015, she joined the Northwestern University Feinberg School of Medicine as an Associate Professor of dermatology and was promoted to Professor of dermatology in 2022. She joined UT Southwestern in 2026.
Education & Training
- Internship - Harvard Medical School/Brigham & Women's Hospital (2003-2004), Internal Medicine
- Residency - Yale New Haven Health System (2004-2007), Dermatology
- Medical Education - Yale University School of Medicine (1999-2003), MD
Books & Publications
Clinical Focus
- Oncodermatology